Skip to content
COMPANY
PRODUCTS
R & D
Product Candidates Overview
Pipeline
Orphan Drug Designations
PARTNERING
INVESTOR RELATIONS
Press Releases
Events & Presentations
Stock Information
SEC Filings
XBRL Filings
Stockholder Meeting
Corporate Governance
Email Alerts
Investor Contact
BLOG
CONTACT
Press Releases
Nov 01, 2001
Hemispherx Biopharma Will Announce New HIV Clinical Treatment Data On Immune Intervention during "Drug Holidays" at WHO Conference
Oct 17, 2001
Hemispherx Awarded U.S. Patent on Novel Fusion Inhibitor of HIV
Oct 04, 2001
HEMISPHERX REPORTS ON PROGRESS IN EUROPE -- Steady Organizational Growth Since February 2000 Prepares Company For European Trials And Product Introduction
Oct 02, 2001
Hemispherx Biopharma Announces Notice Of Warrant Expiration Date
Oct 02, 2001
Hemispherx Scientists Report New Method To Evaluate Chronic Fatigue Syndrome
Jul 24, 2001
HEMISPHERX BIOPHARMA SELECTED BY MSN MONEY CENTRAL'S STOCKSCOUTER AS ONE OF HIGHEST RATED SMALL-CAP BIOTECHS
Jun 25, 2001
HEMISPHERX BIOPHARMA SPONSORS GLOBAL AIDS FUNDRAISER AT UNITED NATIONS
Jun 14, 2001
HEMISPHERX BIOPHARMA INITIATES TREATMENT IN TWO NEW CLINICAL STUDIES OF MULTI-DRUG RESISTANT HIV-INFECTION IN U.S.A.--Culminates 15 Year Period of Discoveries-
May 09, 2001
Hemispherx Biopharma, LabCorp® combine forces for Nationwide testing in HIV Immunotherapy Clinical Trials
77
78
79
80
81
82
<<
<
>
>>
Privacy